Submitted by Anonymous (not verified) on 28 August 2026 - 13:30
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Herzuma, trastuzumab, Date of authorisation: 09/02/2018, Revision: 26, Status: Authorised